clofibrate has been researched along with Diabetes Mellitus in 78 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insulin resistance is a characteristic feature of type II diabetes as well as obesity." | 2.41 | [Discovery and development of a new insulin sensitizing agent, pioglitazone]. ( Fujita, T; Ikeda, H; Kawamatsu, Y; Meguro, K; Sohda, T, 2002) |
| "4 Clofibrate may prove to be a useful adjunct to the treatment of maturity onset diabetes." | 1.26 | Effect of clofibrate on glucose tolerance in maturity onset diabetes. ( Barnett, D; Craig, JG; Robinson, DS; Rogers, MP, 1977) |
| "Bezafibrate was well tolerated, hypoglycaemia or hypoglycaemic reactions were not observed." | 1.26 | [Improvement in diabetes control by treatment with bezafibrate]. ( Rüth, E; Vollmar, J, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 69 (88.46) | 18.7374 |
| 1990's | 3 (3.85) | 18.2507 |
| 2000's | 5 (6.41) | 29.6817 |
| 2010's | 1 (1.28) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Willson, TM | 1 |
| Brown, PJ | 1 |
| Sternbach, DD | 1 |
| Henke, BR | 1 |
| Lin, HR | 1 |
| Sohda, T | 1 |
| Kawamatsu, Y | 1 |
| Fujita, T | 1 |
| Meguro, K | 1 |
| Ikeda, H | 1 |
| OLIVER, MF | 1 |
| Vojtassáková, E | 1 |
| Syneková, M | 1 |
| Tazká, D | 1 |
| Mátyás, S | 1 |
| Hózová, R | 1 |
| Sadlonová, I | 1 |
| Svec, P | 1 |
| Colman, RW | 1 |
| Rüth, E | 1 |
| Vollmar, J | 2 |
| Vogelberg, KH | 4 |
| Dannehl, K | 1 |
| Gries, FA | 1 |
| Janka, HU | 1 |
| Standl, A | 1 |
| Holler, HD | 1 |
| Mehnert, H | 2 |
| Prager, R | 1 |
| Schernthaner, G | 1 |
| Kostner, GM | 1 |
| Mühlhauser, I | 1 |
| Zechner, R | 1 |
| Dorda, W | 1 |
| Pissarek, D | 1 |
| Panzram, G | 1 |
| Lundershausen, R | 1 |
| Adolph, W | 1 |
| Senf, L | 1 |
| Calvert, GD | 1 |
| Blight, L | 1 |
| Franklin, J | 1 |
| Oliver, J | 1 |
| Wise, P | 1 |
| Gallus, AS | 1 |
| Jiraratsatit, J | 1 |
| Keoplung, M | 1 |
| Scherff, R | 1 |
| Schulze-Schleppinghoff, B | 1 |
| Rao, AV | 1 |
| Ramakrishnan, S | 1 |
| Cicmir, I | 1 |
| Heggen, ME | 1 |
| Kusumi, K | 1 |
| Hayashida, A | 1 |
| Boumendil, EF | 1 |
| Balkau, B | 1 |
| Charles, MA | 1 |
| Eschwège, E | 1 |
| Tada, N | 1 |
| Steiner, G | 2 |
| Rumpf, KW | 1 |
| Albers, R | 1 |
| Scheler, F | 1 |
| Cederblad, G | 1 |
| Korsan-Bengtsen, K | 1 |
| Cayen, MN | 1 |
| Dubuc, J | 1 |
| Dvornik, D | 1 |
| Jain, AK | 1 |
| Ryan, JR | 1 |
| McMahon, FG | 1 |
| Stone, MC | 1 |
| Thorp, JM | 1 |
| Wain, JS | 1 |
| Dilman, VM | 1 |
| Kudzma, DJ | 1 |
| Friedberg, SJ | 1 |
| Yü, TF | 1 |
| Dorph, DJ | 1 |
| Smith, H | 1 |
| Daubresse, JC | 2 |
| Daigneux, D | 1 |
| Bruwier, M | 1 |
| Luyckx, A | 1 |
| Lefebvre, PJ | 2 |
| Gatti, A | 1 |
| Carletta, C | 1 |
| Schade, DS | 2 |
| Eaton, RP | 2 |
| George, S | 1 |
| Conway, M | 1 |
| Kaminsky, N | 1 |
| Sivinski, J | 1 |
| Twomey, C | 1 |
| Bloom, A | 1 |
| Ferrari, C | 4 |
| Romussi, M | 3 |
| Bertazzoni, A | 4 |
| Testori, GP | 4 |
| Grimaldi, MG | 1 |
| De Silva, SR | 1 |
| Betteridge, DJ | 1 |
| Shawe, JE | 1 |
| Cudworth, AG | 1 |
| Alberti, KG | 1 |
| Caldara, R | 1 |
| Frezzati, S | 3 |
| Wahl, P | 1 |
| Hasslacher, C | 1 |
| Lang, PD | 1 |
| Häser, C | 1 |
| Rahlfs, V | 1 |
| Pagliano, FM | 1 |
| Bombara, R | 1 |
| Giraldi, B | 1 |
| Visca, U | 1 |
| Haller, H | 2 |
| Michaelis, D | 1 |
| Hanefeld, M | 2 |
| Leonhardt, W | 2 |
| Schulze, J | 1 |
| Antonini, S | 1 |
| Paracchi, A | 1 |
| Pontiroli, AE | 1 |
| Viberti, G | 1 |
| Pozza, G | 1 |
| Barnett, D | 2 |
| Craig, JG | 1 |
| Robinson, DS | 2 |
| Rogers, MP | 2 |
| Singer, P | 1 |
| Gnauck, G | 1 |
| Honigmann, G | 1 |
| Thoelke, H | 1 |
| Schliack, V | 1 |
| Läuter, J | 1 |
| Gemme, G | 1 |
| Olivari, A | 1 |
| Mangiante, G | 1 |
| Luyckx, AS | 1 |
| Dunnigan, MG | 1 |
| Cochrane, MA | 1 |
| Kelly, A | 1 |
| Scott, JW | 1 |
| Albrink, MJ | 1 |
| Suha, E | 1 |
| Zurro Hernández, J | 1 |
| Arribas Castrillo, JM | 1 |
| Durán García, S | 1 |
| Quintero de Juana, A | 1 |
| Romero, E | 1 |
| Maruhama, Y | 1 |
| Yanbe, A | 1 |
| Abe, R | 1 |
| Oneda, A | 1 |
| Yamagata, S | 1 |
| Scapellato, L | 1 |
| Bruns, W | 1 |
| Rjasanowski, I | 1 |
| Wulfert, P | 1 |
| Michael, R | 1 |
| Knospe, S | 1 |
| Hildmann, W | 1 |
| Miettinen, TA | 1 |
| Cullen, JF | 2 |
| Moses, AM | 1 |
| Miller, M | 1 |
| Town, SM | 1 |
| Campbell, CJ | 1 |
| Julius, U | 1 |
| Pettersen, JE | 1 |
| Hohlfeld, R | 1 |
| Neugebauer, A | 1 |
| Haaser, B | 1 |
| Marek, H | 1 |
| Reuter, W | 1 |
| Spesivtseva, VG | 1 |
| Kakhnovskiĭ, IM | 1 |
| Dorokhova, AS | 1 |
| Al'bert, LB | 1 |
| Mirouze, J | 1 |
| Orsetti, A | 1 |
| Cartry, E | 1 |
| Heilman, KM | 1 |
| Fisher, WR | 1 |
| Clarke, BF | 1 |
| Duncan, LJ | 1 |
| Mazovetskiĭ, AG | 1 |
| Alekseev, IuP | 1 |
| Kliachko, VR | 1 |
| Fearnley, GR | 1 |
| Lewis, B | 1 |
| Takayasu, K | 1 |
| Tada, T | 1 |
| Okada, F | 1 |
| Yoshikawa, I | 1 |
| Laursen, B | 1 |
| Gormsen, J | 1 |
| Noleto, PA | 1 |
| de Bulhões, F | 1 |
| Tuma, M | 1 |
| Bergqvist, N | 1 |
| Fanta, D | 1 |
| Formanek, I | 1 |
| Niebauer, G | 1 |
| Warembourg, H | 1 |
| Jaillard, J | 1 |
11 reviews available for clofibrate and Diabetes Mellitus
| Article | Year |
|---|---|
The PPARs: from orphan receptors to drug discovery.
Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligand | 2000 |
[Discovery and development of a new insulin sensitizing agent, pioglitazone].
Topics: Animals; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Diabetes Mellitus, Experimental; D | 2002 |
[Overviews of fibrate].
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL | 2001 |
The use of fibrates and of statins in preventing atherosclerosis in diabetes.
Topics: Anticholesteremic Agents; Arteriosclerosis; Clinical Trials as Topic; Clofibrate; Diabetes Complicat | 2001 |
Hyperlipidemia in primary gout.
Topics: Adolescent; Adult; Aged; Aging; Alcohol Drinking; Cholesterol; Clofibrate; Dextrothyroxine; Diabetes | 1978 |
Effects of various lipid-lowering treatments in diabetics.
Topics: Clofibrate; Diabetes Complications; Diabetes Mellitus; Humans; Hydroxymethylglutaryl-CoA Reductase I | 1990 |
Dietary and drug treatment of hyperlipidemia in diabetes.
Topics: Arteriosclerosis; Blood Protein Disorders; Body Weight; Cholestyramine Resin; Clofibrate; Diabetes M | 1974 |
[Drug prevention of coronary disease].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Cholestyramine Resin; Clofibrate; Coronary Diseas | 1972 |
Diabetic retinopathy: hope or despair.
Topics: Adult; Age Factors; Aged; Clofibrate; Diabetes Mellitus; Diabetic Retinopathy; Female; Humans; Laser | 1972 |
Drug-induced dilutional hyponatremia.
Topics: Acetaminophen; Amitriptyline; Animals; Anura; Body Fluids; Carbamazepine; Chlorpropamide; Clofibrate | 1974 |
Advances in the treatment of diabetes mellitus.
Topics: Blood Glucose; Chlorpropamide; Clofibrate; Diabetes Mellitus; Diabetic Coma; Diabetic Ketoacidosis; | 1971 |
15 trials available for clofibrate and Diabetes Mellitus
| Article | Year |
|---|---|
[Carbohydrate metabolism in bezafibrate therapy. Controlled study of glibenclamide-treated diabetics with hyperlipidemia].
Topics: Aged; Bezafibrate; Carbohydrate Metabolism; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Di | 1982 |
Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.
Topics: Aged; Apolipoprotein A-II; Apolipoproteins; Apolipoproteins A; Apolipoproteins B; Bezafibrate; Chole | 1982 |
[Intensified therapy of newly detected maturity onset diabetes].
Topics: Biguanides; Body Weight; Clofibrate; Diabetes Mellitus; Diet, Diabetic; Female; Glucose Tolerance Te | 1980 |
The effects of clofibrate on plasma glucose, lipoproteins, fibrinogen, and other biochemical and haematological variables in patients with mature onset diabetes mellitus.
Topics: Aged; Blood Glucose; Blood Viscosity; Cholesterol; Clinical Trials as Topic; Clofibrate; Diabetes Me | 1980 |
Combined clofibrate and chlorpropamide in the treatment of maturity - onset diabetes mellitus.
Topics: Adult; Chlorpropamide; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Drug Therapy, Combin | 1980 |
[The influence of clofibrate on glucose metabolism in diabetes mellitus without endogenous hypertriglyceridemia (author's transl)].
Topics: Adult; Aged; Blood Glucose; Clofibrate; Diabetes Mellitus; Female; Humans; Insulin; Male; Middle Age | 1982 |
[The influence of clofibrate on elevated serum lactate levels in diabetic patients treated with biguanides (author's transl)].
Topics: Adult; Biguanides; Body Weight; Clofibrate; Diabetes Mellitus; Enzymes; Female; Humans; Hypoglycemic | 1980 |
Potentiation of hypoglycemic effect of sulfonylureas by halofenate.
Topics: Adult; Clinical Trials as Topic; Clofibrate; Diabetes Complications; Diabetes Mellitus; Drug Synergi | 1975 |
Potentiation of hypoglycemic effect of chlorpropamide and phenfromin by halofenate.
Topics: Blood Glucose; Chlorpropamide; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Drug Synergi | 1977 |
Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents.
Topics: Blood Glucose; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Female; Fibrinogen; Glycosur | 1979 |
Metabolic effects of clofibrate in insulin-dependent ketosis-prone diabetic man.
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Diabetic Ketoac | 1978 |
Clofibrate in insulin-dependent diabetes.
Topics: Adolescent; Adult; Aged; Blood Glucose; Clofibrate; Diabetes Mellitus; Evaluation Studies as Topic; | 1979 |
Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment.
Topics: Alanine; Blood Glucose; Cholesterol; Circadian Rhythm; Clofibrate; Diabetes Mellitus; Drug Synergism | 1979 |
[The question of adverse effects of clofibrate. Experience in patients with diabetes mellitus].
Topics: Aged; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Humans; Middle Aged | 1976 |
Double-blind trial of Atromid-S in exudative diabetic retinopathy.
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Diabetic Retinopathy; Exudates | 1974 |
52 other studies available for clofibrate and Diabetes Mellitus
| Article | Year |
|---|---|
Sesquiterpene lactones from Tithonia diversifolia act as peroxisome proliferator-activated receptor agonists.
Topics: Diabetes Mellitus; Drugs, Chinese Herbal; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interact | 2012 |
ATROMID-S AND ATROMID.
Topics: Androsterone; Arteriosclerosis; Butyrates; Cerebrovascular Disorders; Clofibrate; Coronary Disease; | 1964 |
Effect of VULM 1457, an ACAT inhibitor, on serum lipid levels and on real time red blood cell flow in diabetic and non-diabetic hamsters fed high cholesterol-lipid diet.
Topics: Animals; Blood Flow Velocity; Blood Glucose; Cholesterol; Cholesterol, Dietary; Clofibrate; Cricetin | 2007 |
The role of platelets in the genesis of ischemia.
Topics: Adenosine Diphosphate; Animals; Arteriosclerosis; Blood Platelets; Cholesterol; Clofibrate; Coronary | 1982 |
[Improvement in diabetes control by treatment with bezafibrate].
Topics: Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Diabetes Complications; Diabetes Mellitu | 1982 |
[Disorders of glucose metabolism and manifestation of diabetes during treatment of endogenous hypertriglyceridemias (author's transl)].
Topics: Adult; Aged; Blood Glucose; Cholesterol; Clofibrate; Diabetes Mellitus; Diet, Reducing; Female; Gluc | 1981 |
14C-cholesterol distribution & cholesterol content of various tissues in different applied conditions in rats.
Topics: Aging; Animals; Cholesterol; Clofibrate; Diabetes Mellitus; Ethanol; Hypothyroidism; Rats; Sucrose | 1982 |
[Effects of the hypolipidemic drugs on serum lipids and their fatty acid compositions in diabetic patients (author's transl)].
Topics: Clofibrate; Diabetes Mellitus; Fatty Acids; Female; Humans; Lipids; Male; Phosphatidylcholines | 1981 |
Mortality from non-cardiovascular disease and diabetes mellitus.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cause of Death; Clofibrate; Diabetes Mellitus; Fr | 1998 |
High death rate from neoplasms in French diabetic and non-diabetic men.
Topics: Case-Control Studies; Clofibrate; Diabetes Mellitus; Humans; Hyperlipidemias; Hypolipidemic Agents; | 1998 |
Letter: Clofibrate-induced myopathy syndrome.
Topics: Adult; Clofibrate; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hypothyroidism; Kidney | 1976 |
Effect of clofibrate on plasma proteins including components of the hemostatic mechanism.
Topics: Adult; Arteriosclerosis; Blood Proteins; Clofibrate; Diabetes Mellitus; Fibrinolysin; Hemostasis; Hu | 1976 |
Effect of clofibrate on lipid metabolism in streptozotocin diabetic rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Cholesterol; Clofibrate; Diabetes Mellitus; Eat | 1975 |
Experimental and clinical evaluation of two "Atromid-S" analogues in relation to their differential modes of action.
Topics: Animals; Body Weight; Butyrates; Clofenapate; Clofibrate; Diabetes Mellitus; Fatty Acids, Nonesterif | 1975 |
Ageing, metabolic immunodepression and carcinogenesis.
Topics: Adult; Aged; Aging; Cell Transformation, Neoplastic; Cholesterol; Clofibrate; Coronary Disease; Diab | 1978 |
[Interference of clofibrate in metabolic compensation in dyslipidemic diabetics].
Topics: Adult; Aged; Clofibrate; Diabetes Complications; Diabetes Mellitus; Drug Interactions; Humans; Hyper | 1979 |
Effect of short-term clofibrate on glucose metabolism and insulin secretion in patients with mild maturity-onset diabetes mellitus.
Topics: Blood Glucose; Clofibrate; Diabetes Mellitus; Glucose Tolerance Test; Humans; Insulin; Male; Middle | 1978 |
Increased glucose disappearance rate after short-term clofibrate administration in normal subjects and in patients with chemical diabetes.
Topics: Blood Glucose; Cholesterol; Clofibrate; Diabetes Mellitus; Fatty Acids, Nonesterified; Humans; Insul | 1978 |
[Lipid-lowering effect of bezafibrate in patients with diabetes mellitus and hyperlipidaemia (author's transl)].
Topics: Blood Glucose; Cholesterol; Clofibrate; Diabetes Complications; Diabetes Mellitus; Female; Glycosuri | 1978 |
[Relationship between the manifestation of diabetes and the treatment of hyperlipemia].
Topics: Adult; Aged; Clofibrate; Diabetes Complications; Diabetes Mellitus; Energy Intake; Female; Humans; H | 1978 |
[Changes in lipid metabolism in a case of associated primary hypothyroidism, obesity and diabetes mellitus].
Topics: Aged; Cholesterol; Clofibrate; Diabetes Complications; Diabetes Mellitus; Female; Glyburide; Humans; | 1976 |
[Is primary or secondary prevention of diabetes mellitus in hyperliporoteinemia possible under long-term clofibrate therapy?].
Topics: Clofibrate; Diabetes Mellitus; Humans; Hyperlipidemias; Long-Term Care; Middle Aged; Time Factors | 1976 |
Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia.
Topics: Adolescent; Adult; Aged; Blood Glucose; Cholesterol; Clofibrate; Diabetes Mellitus; Fatty Acids, Non | 1977 |
Growth hormone response to arginine in normal subjects and in patients with chemical diabetes and effect of clofibrate and of metergoline.
Topics: Adult; Aged; Arginine; Clofibrate; Diabetes Mellitus; Ergolines; Female; Glucose Tolerance Test; Gro | 1977 |
Effect of clofibrate on glucose tolerance in maturity onset diabetes.
Topics: Blood Glucose; Clofibrate; Diabetes Mellitus; Female; Glucose Tolerance Test; Humans; Insulin; Male; | 1977 |
[Triglycerides, free fatty acids and cholesterol after fat loading and heparin injection in diabetics with and without hyperlipoproteinemia as well as after clofibrate treatment].
Topics: Cholesterol; Clofibrate; Diabetes Complications; Diabetes Mellitus; Dietary Fats; Fatty Acids, Nones | 1977 |
Effects of clofibrate treatment on plasma triglyceride concentration, plasma post-heparin clearing factor lipase (lipoprotein lipase) activity and serum clearing factor lipase activating ability in maturity-onset diabetes.
Topics: Blood Proteins; Clofibrate; Diabetes Mellitus; Female; Heparin; Humans; Kinetics; Lipoprotein Lipase | 1976 |
Modulation of fatty acid metabolism by glucagon in man. III. Role of pharmacologic limitation of FFA availability.
Topics: Adult; Clofibrate; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; | 1975 |
[Non-hormonal treatment of low specific weight polyuria-polydipsia. Indications and limitations].
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Chlorpropamide; Clofibrate; Diabetes Mellitus; F | 1975 |
Letter: Potentiation of hypoglycemic effect of sulfonylureas by clofibrate.
Topics: Clofibrate; Diabetes Mellitus; Drug Synergism; Humans; Sulfonylurea Compounds | 1976 |
Potentiation of hypoglycemic response to intravenous tolbutamide by clofibrate.
Topics: Clofibrate; Diabetes Mellitus; Drug Synergism; Humans; Tolbutamide | 1976 |
Familial lipoatrophic diabetes with dominant transmission. A new syndrome.
Topics: Adult; Chlorpropamide; Cholesterol; Clofibrate; Diabetes Mellitus; Dietary Carbohydrates; Female; Ge | 1974 |
Letter: Clofibrate treatment of diabetes insipidus.
Topics: Administration, Oral; Adult; Clofibrate; Diabetes Mellitus; Humans; Male | 1974 |
[Prophylaxis of thrombogenesis in the diabetic patient].
Topics: Clofibrate; Diabetes Complications; Diabetes Mellitus; Dipyridamole; Drug Evaluation; Humans; Platel | 1974 |
Effect of clofibrate administration on plasma post-heparin lipolytic activity in man.
Topics: Acetohexamide; Blood Glucose; Cholesterol; Clofibrate; Diabetes Mellitus; Fatty Acids, Nonesterified | 1974 |
[Prevention of diabetic angiopathy or revision of the concept of control and compensation of diabetes and of its practical management].
Topics: Clofibrate; Diabetes Mellitus; Diabetic Angiopathies; Humans; Middle Aged; Nicotinic Acids; Physical | 1974 |
[Differential diagnosis and differential treatment of carbohydrate tolerance disorders in patients with hyperlipoproteinemia. Behavior of plasma lipids, glucose tolerance, and plasma insulin after glucose load during treatment with clofibrate].
Topics: Adult; Blood Glucose; Carbohydrate Metabolism, Inborn Errors; Clofibrate; Diabetes Complications; Di | 1974 |
[Effect of propranolol and chlorophenoxybutyric acid (CPJB) on the dynamics of free fatty acids and blood sugar].
Topics: Blood Glucose; Clofibrate; Diabetes Mellitus; Fatty Acids, Nonesterified; Glucose; Humans; Middle Ag | 1972 |
In vitro studies on the metabolism of hexadecanedioic acid and its mono-L-carnitine ester.
Topics: Acyltransferases; Animals; Carnitine; Clofibrate; Coenzyme A; Diabetes Mellitus; Esters; Fasting; Ma | 1973 |
[Regadrin treatment of diabetes mellitus].
Topics: Adult; Aged; Blood Glucose; Carbohydrate Metabolism; Clofibrate; Diabetes Mellitus; Female; Glycosur | 1973 |
[Therapeutic use of miscleron in patients with diabetes mellitus and cardiovascular disorders].
Topics: Adolescent; Adult; Age Factors; Aged; Cardiovascular Diseases; Clofibrate; Diabetes Complications; D | 1973 |
[Pyridoxine para-chloro-phenoxy-isobutyrate. Analysis of hypolipidemic effects].
Topics: Clofibrate; Diabetes Mellitus; Diet; Drug Evaluation; Humans; Hyperlipidemias; Obesity; Pyridoxine; | 1973 |
Hyperlipidemic dementia.
Topics: Cholesterol; Clofibrate; Dementia; Diabetes Complications; Diabetes Mellitus; Diet Therapy; Diet, Di | 1974 |
[Treatment of diabetic xanthomatosis with Atromid].
Topics: Clofibrate; Diabetes Complications; Diabetes Mellitus; Humans; Male; Middle Aged; Xanthomatosis | 1972 |
[Physiological and pharmacological aspects of fibrinolysis].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Arteriosclerosis Obliterans; Biguanides; Blood Coagulation | 1971 |
Classification of hyperlipidaemias.
Topics: Carbohydrate Metabolism; Cholestyramine Resin; Chylomicrons; Clofibrate; Dextrothyroxine; Diabetes M | 1971 |
Human plasma fatty acid composition: the features of hyperlipoproteinemia and the influence of -linolenate and clofibrate.
Topics: Adult; Aged; Blood Protein Disorders; Cholesterol; Clofibrate; Diabetes Mellitus; Fatty Acids; Fatty | 1971 |
Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
Topics: Adolescent; Adult; Aged; Aminocaproates; Anticholesteremic Agents; Arteriosclerosis; Arthritis, Rheu | 1969 |
[Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate].
Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Clofibrate; Diabetes Mellitus; Female; Huma | 1969 |
Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
Topics: Adolescent; Adult; Age Factors; Aged; Anticholesteremic Agents; Arteriosclerosis; Blood Glucose; Cho | 1970 |
[Behavior of lipoproteins in xanthomatoses].
Topics: Clofibrate; Diabetes Mellitus; Diet Therapy; Humans; Hypoglycemic Agents; Lipoproteins; Obesity; Ski | 1971 |
[Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
Topics: Adult; Aged; Anticholesteremic Agents; Clofibrate; Diabetes Mellitus; Female; Humans; Hyperlipidemia | 1968 |